Pyrrolopyrimidine compounds and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9346810
APP PUB NO 20130210831A1
SERIAL NO

13817802

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure provides pyrrolopyrimidine compounds and methods of use therefor. For example, the disclosure provides certain pyrrolopyrimidine compounds capable of inhibiting JAK kinases. The disclosure further provides the pharmaceutical compositions containing these pyrrolopyrimidine compounds, and use of these pyrrolopyrimidine compounds in the treatment of disorders or diseases, such as inflammatory diseases and cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HUTCHISON MEDIPHARMA LIMITED201203 SHANGHAI ZHANGJIANG HI TECH PARK CAI LUN ROAD NO 4 LANE 720 MUNICIPAL DISTRICT SHANGHAI CITY 201203

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Deng, Wei Shanghai, CN 180 1768
Ji, Jianguo Shanghai, CN 69 1055
Li, Jinshui Shanghai, CN 7 28
Su, Wei-Guo Shanghai, CN 60 343

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 24, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00